Make your money go further for just 25p per day

Settlement disappoints | FDA approvals encourage

06/06/2023 · Advanced Medical Solutions (AMS) · Anexo (ANX) · Diaceutics PLC (DXRX) · Tristel (TSTL) · Watkin Jones (WJG)

AIM AIM Inheritance Tax potential UK

Updates covered here include news of a cash settlement for an unloved legal services business, a significant forward sale for an equally unloved developer and approvals for two more highly rated companies supporting the health sector. Read on here for this and other news.

Diaceutics: significant contract award

Diaceutics (AIM: DXRX), a technology and solutions provider to the pharmaceutical industry, announced a three-year enterprise contract with a US-based top 10 global pharmaceutical company.

The contract will initially deliver US$10.1m of revenue over a three-year period, however, there are additional options which, if exercised, would significantly increase the scope and value over this period. Revenue is expected to be recognised on a monthly basis, spread broadly evenly…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login

Previous article Next article

More on Advanced Medical Solutions

Odd name but great results | Director buying | Retailer woes

17/07/2024 · Company Insights

News covered here includes our assessment of excellent results from a provider of a diverse range…

Episode 9 of the Investor’s Champion Podcast

16/03/2024 · Podcasts

This episode discusses Bitcoin's surging price, the UK competition authority's probe into the veterinary sector, Trainline's growth and…

More on Anexo

Episode 16 of the Investor’s Champion Podcast

04/05/2024 · Podcasts

In this episode of the Investor’s Champion Podcast Chris and Lee run through key news from…

Radical changes | Stunning results | Another takeover

01/05/2024 · Company Insights

It’s always extremely difficult for a business to radically change its operating model, but one rental…

More on Diaceutics PLC

Settlement disappoints | FDA approvals encourage

06/06/2023 · Company Insights

Updates covered here include news of a cash settlement for an unloved legal services business, a…

What is AIM’s exposure to Silicon Valley Bank?

14/03/2023 · Company Insights

One of AIM’s largest companies announced cracking full year results with a big increase in its…

More on Tristel

Plenty of growth/plenty of value

24/07/2024 · Company Insights

Our coverage here includes a highly rated AIM growth stock, which appears to be making progress…

Episode 23 of the Investor’s Champion Podcast

22/06/2024 · Podcasts

In this episode of the Investors Champion podcast, institutional investors' attraction to private equity and the…

More on Watkin Jones

Bonkers Bargain receives an offer | Tough to understand

22/05/2024 · Company Insights

The takeover approaches for UK small caps continue, this time for one of our Bonkers Bargain opportunities.…

Paddling furiously, to go backwards!

23/01/2024 · Company Insights

A popular AIM company covered here is struggling to make a return on substantial revenue –…

More on Advanced Medical Solutions

Odd name but great results | Director buying | Retailer woes

Episode 9 of the Investor’s Champion Podcast

AIM’s world leaders are poised

Merger of equals | Exciting new arrival

More on Anexo

Episode 16 of the Investor’s Champion Podcast

Radical changes | Stunning results | Another takeover

AIM new arrivals July | Improving cash flow

Settlement disappoints | FDA approvals encourage

More on Diaceutics PLC

Settlement disappoints | FDA approvals encourage

What is AIM’s exposure to Silicon Valley Bank?

Buybacks | Contract wins | Warnings | Insolvencies

An exciting play on the growing market of diagnostic data analytics

More on Tristel

Plenty of growth/plenty of value

Episode 23 of the Investor’s Champion Podcast

Director buying and selling | Election delays | Sustainable dividends

Cracking results | Questionable shareholder value

More on Watkin Jones

Bonkers Bargain receives an offer | Tough to understand

Paddling furiously, to go backwards!

Construction commitment | Excellent results | Profit warning

Settlement disappoints | FDA approvals encourage

Flush with cash | Special dividends | Corporate undertakers

Plenty of growth/plenty of value

Bonkers Bargains: poised to recover

ABOUT INVESTORS CHAMPION

Investor's Champion offers objective, incisive and forthright comment on quoted companies and personal finance. Our content addresses what we believe are the key issues in helping make your money go further.

Investor's Champion is a registered trade mark of Investors Champion Ltd. Investor's Champion Limited is a company registered in England and Wales under number 03577867 whose registered office is at c/o Cox Costello & Horne, Batchworth Lock House, 99 Church Street, Rickmansworth, WD3 1JJ.

All rights reserved. © 2007 - 2024